
Diffuse Lewy body disease is the second cause of dementia after Alzheimer's disease. It is characterized by a progressive dementia, often difficult to differentiate from Alzheimer's disease, but fluctuations of cognitive deficits, frequent hallucinations, delirium, hypersensitivity to neuroleptics, unexplained falls, atypical receiving "black-outs" and parkinsonian features are characteristics features evocative of the diagnosis. The response to anticholinesterase medication is often much better than in Alzheimer's disease.
Diagnosis, Differential, Lewy Body Disease, Treatment Outcome, Biopsy, Disease Progression, Prevalence, Humans, Cholinesterase Inhibitors
Diagnosis, Differential, Lewy Body Disease, Treatment Outcome, Biopsy, Disease Progression, Prevalence, Humans, Cholinesterase Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
